OVERVIEW OF SCIENCE AT IMCB

IMCB drives cutting-edge research in several key areas: Cancer Signalling & Therapy, Cell & Molecular Therapy, and Neurometabolism in Health & Disease. This multifaceted approach underscores IMCB's commitment to translating fundamental research into impactful clinical applications and unlocking new possibilities for prevention and treatment. By fostering a collaborative and interdisciplinary environment, IMCB accelerates the discovery of innovative solutions to complex health challenges.
Ìý

Research Divisions

astar-image-placeholder

IMCB’s Research Divisions span three key strategic domains:

  • Cancer Signalling & TherapyÌý: Understanding cancer cell signalling and metabolism to develop innovative therapies.

  • Cell & Molecular TherapyÌý: Developing cutting-edge therapies by integrating molecular engineering, cellular reprogramming, and nucleic acid manipulation for treating various diseases.

  • Neurometabolism in Health & DiseaseÌý: Investigating brain-body interactions, neurometabolism, and cognitive decline to uncover new therapeutic targets.